High Doses and Irregular uses of Amlodipine Besylate are Negatively Affecting the Body is Going to Decline the Growth of the Amlodipine Besylate Market

The global amlodipine besylate market is anticipated to grow at a considerable CAGR of 8.2% during the forecast period (2022-2028). Due to some restraint factors like drowsiness, loss of appetite, weight loss, high heart rate, and swollen gums are some of the side effects that are expected to slow the amlodipine besylate market's growth. Patients don’t prefer the use of amlodipine besylate in their treatment due to the above-mentioned reasons. For instance, in January 2022, According to NCBI, at a dose of 10 mg of amlodipine besylate, the incidence of edema, dizziness, flushing, and palpitations was 10.8%, 3.4%, 2.6%, and 4.5%, respectively. In addition, the incidence of headaches, fatigue, nausea, and abdominal pain was 7.3%, 4.5%, 2.9%, and 1.6%, respectively. For instance, in January 2022 According to NCBI, as a compensatory mechanism, amlodipine overdose and toxicity can cause severe vasodilation, hypotension, and reflex tachycardia. Systemic hypotension that persists can lead to shock and possibly death. Patients who have taken too much amlodipine should be given activated charcoal (AC). Intravenous (IV) fluid resuscitation, IV calcium gluconate, and vasopressor therapy with norepinephrine or dopamine usually resolve the hypotension. High-dose insulin is occasionally used because studies have indicated that it reduces mortality and improves hemodynamics. During an overdose, electrocardiographic data, vital signs, kidney function, urine output, and electrolytes must all be closely monitored.

Browse the full report description “Global Amlodipine Besylate Market Size, Share & Trends Analysis Report by Type (2.5 mg Tablets, 5mg Tablets, and 10mg Tablets), and by Application (High Blood Pressure and Heart Disease) Forecast 2022-2028“at https://www.omrglobal.com/industry-reports/amlodipine-besylate-market

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028

Segment Covered- 

• By Type
• By Application 

Regions Covered-

• North America
• Europe
• Asia-Pacific
• Rest of the World

Competitive Landscape- including Apotex Inc., Aurobindo Pharma Ltd., China Resources Pharmaceutical Group Ltd., Macleods Pharmaceuticals Ltd., Pfizer Inc., and others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Amlodipine Besylate Market Report Segment

By Type

• 2.5mg Tablets
• 5mg Tablets
• 10mg Tablets

By Material

• High Blood Pressure
• Heart Disease

Global Amlodipine Besylate Market Report Segment by Region

North America

• US
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe 

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific 

Rest of the World

• Latin America 
• Middle East & Africa